Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • HCV

    Tag: hcv

    You Searched For "HCV"
    New drug combo effects 97 Percent cure rate in Hepatitis C

    New drug combo effects 97 Percent cure rate in Hepatitis C

    Anjali Nimesh Nimesh18 April 2018 7:20 PM IST
    Over 71 million people suffer from hepatitis worldwide which is responsible for causing 400,000 deaths in a year. World Health Organization aims to...
    EASLs 2018  Recommendations on Treatment of Hepatitis C

    EASL's 2018  Recommendations on Treatment of Hepatitis C

    Dr. Kamal Kant Kohli Kohli20 April 2018 7:02 PM IST
    Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with approximately 71 million chronically infected individuals...
    Screen all people born 1945-1975 for Hepatitis C- New guideline

    Screen all people born 1945-1975 for Hepatitis C- New guideline

    Vinay Singh singh4 Jun 2018 7:05 PM IST
    All people born between 1945 and 1975 to be screened for hepatitis C virus (HCV), according to a key recommendation in a new Canadian guideline...
    Hepatitis-Infected Kidneys a Safe Option for Transplant: Study

    Hepatitis-Infected Kidneys a Safe Option for Transplant: Study

    Medha Baranwal Baranwal11 Aug 2018 7:28 PM IST
    Kidneys from hepatitis C virus (HCV)-infected donors may be a valuable resource for kidney transplants, finds a new study published in the Annals of...
    Is near zero risk blood possible? by Dr R.N. Makroo

    Is near zero risk blood possible? by Dr R.N. Makroo

    Dr. Kamal Kant Kohli Kohli4 Sept 2018 7:04 PM IST
    A blood transfusion service has become an integral part of modern medical practice. Most transfusions save lives, but they can also put a patient at...
    Universally screen pregnant women for Hepatitis C : AASLD study

    Universally screen pregnant women for Hepatitis C : AASLD study

    Vinay Singh singh26 Nov 2018 7:30 PM IST
    Universal screening of pregnant women at risk of hepatitis C virus (HCV) infection is more efficient and cost-effective than risk-based screening,...
    Researchers identify new strains of hepatitis C in Africa

    Researchers identify new strains of hepatitis C in Africa

    Hina Zahid19 Dec 2018 7:10 PM IST
    Researchers at Wellcome Sanger Institute, the MRC-University of Glasgow Centre for Virus Research and collaborators have identified three new strains...
    FDA approves first ever Hepatitis C treatment for pediatric patients

    FDA approves first ever Hepatitis C treatment for pediatric patients

    Dr. Kamal Kant Kohli Kohli30 April 2019 7:22 PM IST
    FDA approves first ever Hepatitis C treatment for pediatric patients.The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and...
    FDA warning: Hepatitis C drugs causing rare liver injury in patients with liver disease

    FDA warning: Hepatitis C drugs causing rare liver injury in patients with liver disease

    Medha Baranwal Baranwal29 Aug 2019 7:15 PM IST
    Some drugs used for the treatment of chronic hepatitis C (HCV) may cause serious liver injury or failure in some patients with advanced liver disease,...
    FDA approves new treatment for hepatitis C virus and compensated cirrhosis

    FDA approves new treatment for hepatitis C virus and compensated cirrhosis

    Medha Baranwal Baranwal26 Sept 2019 7:05 PM IST
    USA: Mavyret (glecaprevir and pibrentasvir) tablets have received FDA's approval for an eight-week duration for the treatment of adults and children...
    Prev

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 12 Oct 2022 7:06 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok